Martin Meglasson - Chief Scientific Officer, Bellerophon Therapeutics, Inc

As of May 22, 2015


Martin Meglasson Net Worth

  • Net worth is estimated to be at least $161.76K
  • Owns at least 19,098 units of Bellerophon Therapeutics, Inc stock

Martin Meglasson Trading

  • Largest purchase of shares was 12,000 units , worth over $144K on February 23, 2015
  • In total has made about 4 transactions over 3 months
  • Usually trades in February, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Martin Meglasson Mailing Address

  • Mailing address is 53 Frontage Road, Suite 301 Hampton NJ 08827 NJ

Bellerophon Therapeutics, Inc Insider Trading

  • The most recent transaction was 400,000 units sold on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky worth over $2.19M
  • In the last 6 years, insiders at Bellerophon Therapeutics, Inc sold an estimated value of $3.99M and bought an estimated value of $74.83M
  • The most active traders are Jonathan M Peacock,  Theodore T Wang,  and Peter Fernandes, CHIEF REGULATORY & SAFETY OFFR
  • Insider trading is most common in September, with the busiest year in 2018

Bellerophon Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1